Robert Hawkins

Direttore/Membro del Consiglio presso BIVICTRIX THERAPEUTICS PLC

Patrimonio netto: 35 552 $ in data 30/06/2024

69 anni

Consumer Services

Health Technology

Posizioni attive di Robert Hawkins

Società	Posizione	Inizio	Fine
BIVICTRIX THERAPEUTICS PLC	Direttore/Membro del Consiglio	22/09/2021	-
BIVICTRIX THERAPEUTICS PLC	Independent Dir/Board Member	22/09/2021	-

Società	Posizione	Inizio	Fine
INSTIL BIO, INC.	Direttore Tecnico/Scientifico/R&S	11/11/2022	01/05/2024
INSTIL BIO, INC.	Direttore/Membro del Consiglio	01/02/2019	01/07/2020
Instil Bio (UK) Ltd.	Amministratore Delegato	-	01/01/2020
Instil Bio (UK) Ltd.	Fondatore	-	01/01/2020
The University of Manchester	Corporate Officer/Principal	-	-
MOTIF BIO PLC	Direttore/Membro del Consiglio	14/06/2021	-

University of Cambridge	Doctorate Degree
University College London	Doctorate Degree

Distribuzione geografica

Regno Unito	7
Stati Uniti	2

Posizioni

Director/Board Member	3
Doctorate Degree	2
Independent Dir/Board Member	1

Settori

Consumer Services	4
Health Technology	4

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
BIVICTRIX THERAPEUTICS PLC	Health Technology
INSTIL BIO, INC.	Health Technology

Aziende private	2
Instil Bio (UK) Ltd.
Motif Bio Plc Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ.	Health Technology

Aziende private

Instil Bio (UK) Ltd.

Health Technology